RPG Life Sciences Ltd.

2,030.5

-15.3 (-0.7%)growUp

As on April 29, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap3,356 Cr
P/E Ratio18.33
Dividend Yield0.15 %
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open2,047
High2,087.9
NSE SymbolRPGLIFE
Close2,030.5
Low2,022.4
BSE Symbol532983
Previous Years High/Low
1 Year High2,725
3 Year High2,974.95
5 Year High2,974.95
1 Year Low1,733
3 Year Low748.6
5 Year Low421.8

Technicals


IndicatorsValueSignal
5-DMA2,026.52Bullish
10-DMA2,003.6Bullish
20-DMA1,946.1Bullish
50-DMA1,914.01Bullish
100-DMA2,067.27Bearish
200-DMA2,214.67Bearish

Historical Performance


1 Year
-6.6%
3 Years
142.5%
5 Years
314.2%
10 Years
653.4%

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:22.4
5 Years:33.2
3 Years:34.3
TTM:-2.9
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a moderate PE of 18.33, suggesting fair valuation relative to earnings.
  • Over the last three years, the stock delivered a strong 3-year price CAGR of 36.6%, indicating sustained price appreciation.
  • The stock carries a low beta of 0.7, suggesting lower volatility than the broader market.
  • In the last financial year, the company reported an EBITDA of ₹1733 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹6534 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 970927.2
No. of Shares: 478 (Approx)
Performance:-2.9%
P/L: ₹-29072.8
NIFTY Performance: -0.6%
1 day Top Gainers
SymbolChange%
SAPPHIRE207.42(19%)
DEVYANI127.59(14%)
BANDHANBNK198.3(11%)
EMCURE1729.9(8%)
GODFRYPHLP2275.3(8%)
1 Day Top Losers
SymbolChange%
COHANCE467.55(-5%)
NTPCGREEN110.53(-5%)
JINDALSAW229.8(-4%)
TARIL323.5(-4%)
INDIACEM401.85(-4%)
JSWINFRA273.14(-4%)
ABSLAMC1024.1(-4%)
JSWENERGY560.4(-4%)

Top Performing Stocks from the same sector


Aarey Drugs & Pharmaceuticals Ltd.

61.9%

90.51

1 Month Performance

Balaxi Pharmaceuticals Ltd.

61.9%

26.68

1 Month Performance

Cohance Lifesciences Ltd.

54.5%

467.55

1 Month Performance

Vaishali Pharma Ltd.

53.3%

7.94

1 Month Performance

Valiant Laboratories Ltd.

52.4%

81.65

1 Month Performance

Gujarat Themis Biosyn Ltd.

49.2%

375.64

1 Month Performance

Kopran Ltd.

38.5%

157.13

1 Month Performance

Krebs Biochemicals & Industries Ltd.

36.8%

60

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month